Stories > 89bio to Present pegozafermin for NASH and SHTG Treatment at Healthcare Conference

89bio to Present pegozafermin for NASH and SHTG Treatment at Healthcare Conference

Advancements in Cancer Treatment and Mar...

Amgen's Obesity Prospects and Q4 Results...

AnaMar Receives Orphan Drug Designation ...

ANJESO Drug Insight and Market Forecast

Anima Biotech's Promising Lung Fibrosis ...

Aquadex SmartFlow® System's Potential